RNA cleaving '10‐23'DNAzymes with enhanced stability and activity

…, DC GuÈl, HP Grunert, H Zeichhardt… - Nucleic acids …, 2003 - academic.oup.com
‘10‐23’ DNAzymes can be used to cleave any target RNA in a sequence‐specific manner.
For applications in vivo, they have to be stabilised against nucleolytic attack by the …

Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction

…, W Poller, F Spillmann, H Zeichhardt… - Cardiovascular …, 2002 - academic.oup.com
Objective: Myocardial collagen degradation is regulated by matrix metalloproteinases (MMPs)
and tissue inhibitors of matrix metalloproteinase (TIMPs). The possible relevance of MMPs …

Carvedilol improves left ventricular function in murine coxsackievirus‐induced acute myocarditis Association with reduced myocardial interleukin‐1β and MMP‐8 …

…, LP Schwimmbeck, H Zeichhardt… - European journal of …, 2005 - Wiley Online Library
Background Proinflammatory cytokines induce the expression of matrix metalloproteinases
that play a crucial role in myocardial remodeling. Beta‐adrenergic receptor stimulation …

The dangers of using Cq to quantify nucleic acid in biological samples: a lesson from COVID-19

…, YK Bae, CA Foy, J Braybrook, H Zeichhardt… - Clinical …, 2022 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA quantities,
measured by reverse transcription quantitative PCR (RT-qPCR), have been proposed to …

RNA reference materials with defined viral RNA loads of SARS-CoV-2—A useful tool towards a better PCR assay harmonization

…, A Kummrow, T Keller, I Schellenberg, H Zeichhardt… - PloS one, 2022 - journals.plos.org
SARS-CoV-2, the cause of COVID-19, requires reliable diagnostic methods to track the
circulation of this virus. Following the development of RT-qPCR methods to meet this diagnostic …

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3–induced myocarditis

…, C Tschope, A Stroux, H Zeichhardt… - Journal of the American …, 2013 - jacc.org
Objectives : This study sought to evaluate the role of protease-activated receptor-2 (PAR2)
in coxsackievirus B3 (CVB3)–induced myocarditis. Background : An infection with CVB3 …

Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor

…, T Größl, S Krohn, C Tschöpe, H Zeichhardt… - Circulation, 2009 - Am Heart Assoc
Background— Group B coxsackieviruses (CVBs) are the prototypical agents of acute
myocarditis and chronic dilated cardiomyopathy, but an effective targeted therapy is still not …

Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2

…, J Vandesompele, C Wittwer, H Zeichhardt - Clinical …, 2020 - academic.oup.com
Reverse transcription (RT)-PCR, the principal diagnostic method applied in the worldwide
struggle against COVID-19, is capable of detecting a single molecule of a viral genome. …

Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy

…, X Wang, L Suckau, J Kurreck, H Zeichhardt… - Journal of Molecular …, 2008 - Springer
RNA interference (RNAi) has potential to be a novel therapeutic strategy in diverse areas of
medicine. In this paper, we report on targeted RNAi for the treatment of a viral …

Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population

M Schmidt, S Hoehl, A Berger, H Zeichhardt… - …, 2020 - Wiley Online Library
Background In the pandemic, testing for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
by real‐time polymerase chain reaction is one of the pillars on which …